2.2.0.25truefalse42601 - Disclosure - LEGAL PROCEEDINGS AND CONTINGENCIES (Narrative) (Details)truefalseIn Millions, except Per Share data, unless otherwise specifiedfalse1falsefalseUSDfalsefalse1/1/2010 - 12/31/2010
USD ($)
USD ($) / shares
$Duration_1_1_2010_To_12_31_2010http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Divide<
MeasureSchema>http://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0USDUSD$2falsefalseUSDfalsefalse1/1/2009 - 12/31/2009
USD ($)
USD ($) / shares
$Duration_1_1_2009_To_12_31_2009http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0USDUSD$3falsefalseUSDfalsefalse1/1/2008 - 12/31/2008
USD ($)
USD ($) / shares
$Duration_1_1_2008_To_12_31_20083http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00Unit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170Unit15Standardhttp://www.xbrl.org/2003/instancesharesxbrli0Unit13Standardhttp://www.xbrl.org/2003/instancepurexbrli0Unit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$4falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Securities Litigation Settlement [Member]
1/1/2010 - 12/31/2010
USD ($)
$Duration_1_1_2010_To_12_31_2010824http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseSecurities Litigation Settlement [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SecuritiesLitigationSettlementMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Securities Litigation Settlement [Member]
1/1/2009 - 12/31/2009
USD ($)
$Duration_1_1_2009_To_12_31_20092282http://www.sec.gov/CIK0000014272duration2009-01-01T00:00:002009-12-31T00:00:00falsefalseSecurities Litigation Settlement [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_SecuritiesLitigationSettlementMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Plavix Litigation US [Member]
10/1/2010 - 10/31/2010
USD ($)
$Duration_10_1_2010_To_10_31_201022http://www.sec.gov/CIK0000014272duration2010-10-01T00:00:002010-10-31T00:00:00falsefalsePlavix Litigation US [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_PlavixLitigationUsMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://ww
w.xbrl.org/2003/iso4217USDiso42170USDUSD$7falsefalsetruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Plavix Litigation US [Member]
1/1/2010 - 12/31/2010
Duration_1_1_2010_To_12_31_20102215http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalsePlavix Litigation US [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_PlavixLitigationUsMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit13Standardhttp://www.xbrl.org/200
3/instancepurexbrli08falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Plavix Litigation US [Member]
11/13/2008
USD ($)
$As_Of_11_13_2008http://www.sec.gov/CIK0000014272instant2008-11-13T00:00:000001-01-01T00:00:00falsefalsePlavix Litigation US [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_PlavixLitigationUsMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso
4217USDiso42170USDUSD$9falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Average Wholesale Price Litigation [Member]
{dei_LegalEntityAxis} : Common Wealth of Pennsylvania [Member]
9/30/2010
USD ($)
$As_Of_9_30_20102http://www.sec.gov/CIK0000014272instant2010-09-30T00:00:000001-01-01T00:00:00falsefalseAverage Wholesale Price Litigation [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_AverageWholesalePriceLitigationMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseCom
mon Wealth of Pennsylvania [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_CommonWealthOfPennsylvaniaMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$10falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Average Wholesale Price Litigation [Member]
{dei_LegalEntityAxis} : District of Massachusetts [Member]
8/31/2009
USD ($)
$As_Of_8_31_2009http://www.sec.gov/CIK0000014272instant2009-08-31T00:00:000001-01-01T00:00:00falsefalseAverage Wholesale Price Litigation [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_AverageWholesalePriceLitigationMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberfalsefalseDist
rict of Massachusetts [Member]dei_LegalEntityAxisxbrldihttp://xbrl.org/2006/xbrldibmy_DistrictOfMassachusettsMemberdei_LegalEntityAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Environmental Proceedings, CERCLA Matters [Member]
12/31/2010
USD ($)
$As_Of_12_31_20103169http://www.sec.gov/CIK0000014272instant2010-12-31T00:00:000001-01-01T00:00:00falsefalseEnvironmental Proceedings, CERCLA Matters [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_EnvironmentalProceedingsCerclaMattersMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$12falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Other Proceedings, Medarex Shareholder Litigation [Member]
7/22/2009
USD ($) / shares
$As_Of_7_22_2009http://www.sec.gov/CIK0000014272instant2009-07-22T00:00:000001-01-01T00:00:00falsefalseOther Proceedings, Medarex Shareholder Litigation [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_OtherProceedingsMedarexShareholderLitigationMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit12Dividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instancesharesxbrli0USDUSD$13falsefalsetruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : Hormone Replacement Therapy [Member]
1/1/2010 - 12/31/2010
Duration_1_1_2010_To_12_31_20102214http://www.sec.gov/CIK0000014272duration2010-01-01T00:00:002010-12-31T00:00:00falsefalseHormone Replacement Therapy [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_HormoneReplacementTherapyMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit13Standardhttp://ww
w.xbrl.org/2003/instancepurexbrli014falsefalsetruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : New Brunswick Facility - Environmental & Personal Injury Lawsuits [Member]
5/1/2008 - 5/31/2008
Duration_5_1_2008_To_5_31_2008http://www.sec.gov/CIK0000014272duration2008-05-01T00:00:002008-05-31T00:00:00falsefalseNew Brunswick Facility - Environmental & Personal Injury Lawsuits [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_NewBrunswickFacilityEnvironmentalAndPersonalInjuryLawsuitsMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit13Standardhttp://www.xbrl.org/2003/instancepurexbrli015falsefalseUSDtruefalse{us-gaap_LossContingenciesByNatureOfContingencyAxis} : AWP Litigation [Member]
1/1/2008 - 12/31/2008
USD ($)
$Duration_1_1_2008_To_12_31_20083214http://www.sec.gov/CIK0000014272duration2008-01-01T00:00:002008-12-31T00:00:00falsefalseAWP Litigation [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldibmy_AwpLitigationMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberUnit1Standardhttp://www.xbrl.org
/2003/iso4217USDiso42170USDUSD$2false0us-gaap_LegalFeesus-gaaptruedebitdurationNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1truefalsefalse-19000000-19falsetruefalsefalsefalse2truefalsefalse132000000132<
CurrencyCode />falsetruefalsefalsefalse3truefalsefalse3300000033falsetruefalsefalsefalse4truefalsefalse4100000041falsetruefalsetruefalse5truefalsefalse125000000125falsetruefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00<
CurrencyCode />falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00<
CurrencySymbol />falsefalsefalsetruefalse15truefalsefalse3300000033falsetruefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of expense provided in the period for legal costs incurred on or before the bal
ance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9
falsefalse3false0bmy_SignificantLitigationCashPaymentsbmyfalsedebitdurationThe amount of cash paid during the period as a result of significant litigation.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse60000006falsefalsefalsefalsefalse2truefalsefalse139000000139falsefalsefalsefalsefalse<
Id>3truefalsefalse210000000210falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7
falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13f
alsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15false<
/IsNumeric>falsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of cash paid during the period as a result of significant litigation.No authoritative reference available.falsefalse4false0bmy_LitigationDamagesAwardedbmyfalsecreditdurationThe amount of damages awarded during the period.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00<
CurrencyCode />falsefalsefalsetruefalse6truefalsefalse442000000442falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of damages awarded during the period.No authoritative reference available.falsefalse5false0bmy_DamagesSoughtLawsuitFiledByThirdPartybmyfalsecreditinstantThe amount of damages sought from a third party related to lit
igation.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse
8truefalsefalse6000000060falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse
10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryThe amount of damages sought from a third party related to litigation.No authoritative reference available.falsefalse6false0us-gaap_LossContingencyEstimateOfPossibleLossus-gaaptruedebitinstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9truefalsefalse2760000027.6falsefalsefalsetruefalse10truefalsefalse1900000019.0falsefalsefalsetruefalse11truefalsefalse6800000068.0falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseMonetaryxbrli:monetaryItemTypemonetaryReflects the estimated amount of loss from the specified contingency as of the balance
sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
falsefalse7false0bmy_DefendantInNumberOfLawsuitsFiledbmyfalsenadurationThe number of lawsuits in which the Company was a defendant.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7truefalsefalse2020falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse300300falsefalsefalsetruefalse14truefalsefalse100100falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:positiveIntegerItemTypepositiveintegerThe number of lawsuits in which the Company was a defendant.No authoritative reference available.falsefalse8false0bmy_NumberO
fPlaintiffsInFederalAndStateCourtsbmyfalsenadurationThe number of plaintiffs in certain lawsuits filed against the Company.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13truefalsefalse450450falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:positiveIntegerItemTypepositiveintegerThe number of plaintiffs in certain lawsuits filed against the Company.No authoritative reference available.falsefalse9false0bmy_DistrictCourtGrantedPreliminaryApprovalOfHalfCostsOfClassNoticebmyfalsecreditinstantThe maximum amount of payments for half of the costs of the class notice.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10truefalsefalse10000001falsetruefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalse
truefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetrue<
/hasSegments>falseMonetaryxbrli:monetaryItemTypemonetaryThe maximum amount of payments for half of the costs of the class notice.No authoritative reference available.falsefalse10false0bmy_AcquisitionOfBusinessCashOfferedPerSharebmyfalsenainstantThe amount of cash offered per share through a tender offer related to the acquisition of a business.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseterselabel1falsefalsefalse00falsefalsefalsefalsefalse2falsefals
efalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalse<
DisplayZeroAsNone>false00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12truefalsef
alse16.0016.00falsetruefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseEPSus-types:perShareI
temTypedecimalThe amount of cash offered per share through a tender offer related to the acquisition of a business.No authoritative reference available.falsetrue11false0us-gaap_LossContingencyPendingClaimsNumberus-gaaptruenainstantNo definition available.falsefalsefalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalsefalse3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7truefalsefalse1818falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00false
falsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:integerItemTypeintegerThe total amount of pending claims pertaining to a loss contingency accrual as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/pre
sentationRef
-Publisher FASB
-Name Statement of Financial Accounting Standard (FAS)
-Number 5
-Paragraph 9, 10, 11, 12
falsefalse12false0bmy_NumberOfPlaintiffsSettlementResolvedbmyfalsenadurationThe number of plaintiffs whose claims are to be resolved as a result of entering into two separate settlements in principle.falsefalsefalsefalsefalsefalsefalsefalsefalsefalseverboselabel1truefalsefalse200200falsefalsefalsefalsefalse2falsefalsefalse00falsefalsefalsefalse
false3falsefalsefalse00falsefalsefalsefalsefalse4falsefalsefalse00falsefalsefalsetruefalse<
/hasScenarios>5falsefalsefalse00falsefalsefalsetruefalse6falsefalsefalse00falsefalsefalsetruefalse7falsefalsefalse00falsefalsefalsetruefalse8falsefalsefalse00falsefalsefalsetruefalse9falsefalsefalse00falsefalsefalsetruefalse10falsefalsefalse00falsefalsefalsetruefalse11falsefalsefalse00falsefalsefalsetruefalse12falsefalsefalse00falsefalsefalsetruefalse13falsefalsefalse00falsefalsefalsetruefalse14falsefalsefalse00falsefalsefalsetruefalse15falsefalsefalse00falsefalsefalsetruefalseOtherxbrli:positiveIntegerItemTypepositiveintegerThe number of plaintiffs whose claims are to be resolved as a result of entering into two separate settlements in principle.No authoritative reference available.falsefalse1511LEGAL PROCEEDINGS AND CONTINGENCIES (Narrative) (Details) (USD $)MillionsUnKnownNoRoundingUnKnowntruetrue
